Related Experiment Video
Updated: Jul 25, 2025

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's
Qinfang Liu1, Dong Zhu1, Naren Li2
1Department of Neuroscience, University of Connecticut School of Medicine, Farmington, CT, USA.
Abstract:
Mutations in LRRK2 are the most common genetic causes of Parkinson's disease (PD). While the enzymatic activity of LRRK2 has been linked to PD, previous work has also provided support for an important role of elevated LRRK2 protein levels, independent of enzymatic activity, in PD pathogenesis. However, the mechanisms underlying the regulation of LRRK2 protein levels remain unclear. Here, we identify a role for the purine biosynthesis pathway enzyme ATIC in the regulation of LRRK2 levels and toxicity. AICAr, the precursor of ATIC substrate, regulates LRRK2 levels in a cell-type-specific manner in vitro and in mouse tissue. AICAr regulates LRRK2 levels through AUF1-mediated mRNA decay. Upon AICAr treatment, the RNA binding protein AUF1 is recruited to the AU-rich elements (ARE) of LRRK2 mRNA leading to the recruitment of the decapping enzyme complex DCP1/2 and decay of LRRK2 mRNA. AICAr suppresses LRRK2 expression and rescues LRRK2-induced dopaminergic neurodegeneration and neuroinflammation in PD Drosophila and mouse models. Together, this study provides insight into a novel regulatory mechanism of LRRK2 protein levels and function via LRRK2 mRNA decay that is distinct from LRRK2 enzymatic functions.
Insights
AICAr regulates Parkinson
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD).
- Both LRRK2 enzymatic activity and elevated LRRK2 protein levels are implicated in PD pathogenesis.
- Mechanisms regulating LRRK2 protein levels are not fully understood.
Purpose of the Study:
- To investigate the role of the purine biosynthesis enzyme ATIC in regulating LRRK2 levels and toxicity.
- To elucidate the mechanism by which AICAr affects LRRK2 expression and PD-related pathology.
Main Methods:
- Investigated the effect of AICAr on LRRK2 levels in vitro and in mouse models.
- Examined the role of AUF1-mediated mRNA decay in LRRK2 regulation.
- Assessed LRRK2-induced neurodegeneration and neuroinflammation in Drosophila and mouse models of PD.
Main Results:
- AICAr, a precursor for ATIC substrate, regulates LRRK2 protein levels in a cell-type-specific manner.
- AICAr induces LRRK2 mRNA decay via recruitment of AUF1 to AU-rich elements (AREs), leading to DCP1/2 complex recruitment.
- AICAr treatment suppressed LRRK2 expression and rescued LRRK2-induced neurodegeneration and neuroinflammation in PD models.
Conclusions:
- Identified a novel regulatory mechanism for LRRK2 protein levels through AICAr-mediated mRNA decay.
- This mechanism is independent of LRRK2 enzymatic activity and offers a new therapeutic target for Parkinson's disease.
- AICAr demonstrates potential in rescuing LRRK2-associated neurotoxicity and neuroinflammation.
Related Concept Videos
Regulated Protein Degradation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Experimental RNAi
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Regulation of Expression at Multiple Steps

